Though London, S. J. et al. declared that subjects with higher serum levels of IGFBP-3 were at reduced risk of lung cancer from a prospective study of men in China [16], the pooled data didn’t show telltale of the function of high circulating IGFBP-3 level to reduced risk of lung cancer. This evidence concerns the gene IGFBP3 and lung carcinoma.